| Date Filed | Type | Description |
| 05/26/2023 |
SC 13D/A
| HealthCor Management, L.P. reports a 63.1% stake in CareView Communications, Inc. |
| 04/03/2023 |
SC 13D/A
| HealthCor Management, L.P. reports a 63.3% stake in CareView Communications, Inc. |
| 02/14/2023 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Research Alliance Corp. II |
| 01/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/15/2022 |
SC 13D/A
| HealthCor Management, L.P. reports a 29.4% stake in CareView Communications, Inc. |
| 07/01/2022 |
SC 13D/A
| HealthCor Management, L.P. reports a 30.5% stake in CareView Communications, Inc. |
| 03/10/2022 |
SC 13D/A
| HealthCor Management, L.P. reports a 30% stake in CareView Communications, Inc. |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 8.6% stake in Research Alliance Corp. II |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Medicus Sciences Acquisition Corp |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Madrigal Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Aurinia Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in ARYA Sciences Acquisition Corp IV |
| 01/04/2022 |
SC 13D/A
| HealthCor Management, L.P. reports a 28.9% stake in CareView Communications, Inc. |
| 10/04/2021 |
SC 13D/A
| HealthCor Management, L.P. reports a 28.4% stake in CareView Communications, Inc. |
| 07/01/2021 |
SC 13D/A
| HealthCor Management, L.P. reports a 27.9% stake in CareView Communications, Inc. |
| 04/22/2021 |
SC 13D/A
| HealthCor Management, L.P. reports a 27.3% stake in CareView Communications, Inc. |
| 04/01/2021 |
SC 13D/A
| HealthCor Management, L.P. reports a 27% stake in CareView Communications, Inc. |
| 03/29/2021 |
SC 13G
| HealthCor Management, L.P. reports a 6.5% stake in Research Alliance Corp. II |
| 03/08/2021 |
SC 13G
| HealthCor Management, L.P. reports a 7.4% stake in ARYA Sciences Acquisition Corp IV |
| 02/26/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Intersect ENT, Inc. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 5.8% stake in Madrigal Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in ViewRay, Inc. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 0.5% stake in Nevro, Corp. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 5.5% stake in Aurinia Pharmaceuticals Inc. |
| 02/12/2021 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Arcturus Therapeutics Holdings Inc |
| 01/05/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/02/2020 |
SC 13D/A
| HealthCor Management, L.P. reports a 26% stake in CareView Communications, Inc. |
| 09/11/2020 |
SC 13G
| HealthCor Management, L.P. reports a 6.5% stake in Arcturus Therapeutics Holdings Inc |
| 07/02/2020 |
SC 13D/A
| HealthCor Management, L.P. reports a 25.5% stake in CareView Communications, Inc. |
| 03/27/2020 |
SC 13G
| HealthCor Management, L.P. reports a 5.5% stake in Nevro, Corp. |
| 02/14/2020 |
SC 13G/A
| HealthCor Management, L.P. reports a 8% stake in Intersect ENT, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|